The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 19, 2016

Filed:

Nov. 11, 2013
Applicant:

Medtronic, Inc., Minneapolis, MN (US);

Inventors:

Mary M. Morris, Shoreview, MN (US);

Mark A. Bellrichard, Champlin, MN (US);

Robert Garfield, Cincinnati, OH (US);

Daniel Gelfman, Golden Valley, MN (US);

Lu Wang, Minneapolis, MN (US);

Michael W. Kimmel, Edina, MN (US);

Karen J. Kleckner, New Brighton, MN (US);

Brian W. Ball, Maple Grove, MN (US);

Assignee:

MEDTRONIC, INC., Minneapolis, MN (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 5/172 (2006.01); A61M 5/142 (2006.01); G06F 19/00 (2011.01); A61M 5/14 (2006.01); A61M 5/168 (2006.01);
U.S. Cl.
CPC ...
A61M 5/172 (2013.01); G06F 19/3468 (2013.01); A61M 5/142 (2013.01); A61M 5/1407 (2013.01); A61M 5/14244 (2013.01); A61M 5/168 (2013.01); A61M 5/16827 (2013.01); A61M 2205/3379 (2013.01); A61M 2205/52 (2013.01);
Abstract

Devices, systems, and techniques for transitioning between different drug delivery sources or different drug concentrations may account for diffusion and mixing of drug within the fluid. In one example, a method may include determining a flow rate for a fluid to be delivered to a patient via a drug pump and a catheter in fluid communication with a reservoir of the drug pump. The fluid includes a drug. The method also includes determining a concentration profile of the drug delivered via the catheter, wherein the concentration profile identifies a volume of delivered fluid needed to achieve a target transition dose of the drug. The method further includes determining, by a processor and based on the flow rate and the concentration profile, an initial delivery period required to achieve the target transition dose by delivering the fluid at the flow rate.


Find Patent Forward Citations

Loading…